176 related articles for article (PubMed ID: 38272193)
1. Calreticulin P-domain-derived "Eat-me" peptides for enhancing liposomal uptake in dendritic cells.
Mei KC; Thota N; Wei PS; Yi B; Bonacquisti EE; Nguyen J
Int J Pharm; 2024 Mar; 653():123844. PubMed ID: 38272193
[TBL] [Abstract][Full Text] [Related]
2. An "eat me" combinatory nano-formulation for systemic immunotherapy of solid tumors.
Abdel-Bar HM; Walters AA; Lim Y; Rouatbi N; Qin Y; Gheidari F; Han S; Osman R; Wang JT; Al-Jamal KT
Theranostics; 2021; 11(18):8738-8754. PubMed ID: 34522209
[No Abstract] [Full Text] [Related]
3. Precise Delivery of Nanomedicines to M2 Macrophages by Combining "Eat Me/Don't Eat Me" Signals and Its Anticancer Application.
Tang Y; Tang Z; Li P; Tang K; Ma Z; Wang Y; Wang X; Li C
ACS Nano; 2021 Nov; 15(11):18100-18112. PubMed ID: 34751571
[TBL] [Abstract][Full Text] [Related]
4. Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity.
Liu M; Li W; Larregieu CA; Cheng M; Yan B; Chu T; Li H; Mao SJ
Mol Pharm; 2014 Jul; 11(7):2305-12. PubMed ID: 24830852
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles in phagocytosis of the early and late increases of cell surface calreticulin induced by oxaliplatin.
Matsusaka K; Azuma Y; Kaga Y; Uchida S; Takebayashi Y; Tsuyama T; Tada S
Biochem Biophys Rep; 2022 Mar; 29():101222. PubMed ID: 35146135
[TBL] [Abstract][Full Text] [Related]
6. Molecular insight for the role of key residues of calreticulin in its binding activities: A computational study.
Yang H; Ahmad ZA; Song Y
Comput Biol Chem; 2020 Apr; 85():107228. PubMed ID: 32062378
[TBL] [Abstract][Full Text] [Related]
7. A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes.
Stefanick JF; Ashley JD; Kiziltepe T; Bilgicer B
ACS Nano; 2013 Apr; 7(4):2935-47. PubMed ID: 23421406
[TBL] [Abstract][Full Text] [Related]
8. SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin.
Berwin B; Delneste Y; Lovingood RV; Post SR; Pizzo SV
J Biol Chem; 2004 Dec; 279(49):51250-7. PubMed ID: 15371419
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
[TBL] [Abstract][Full Text] [Related]
10. Uptake Kinetics Of Liposomal Formulations of Differing Charge Influences Development of in Vivo Dendritic Cell Immunotherapy.
Nagy NA; Castenmiller C; Vigario FL; Sparrius R; van Capel TMM; de Haas AM; van Kooyk Y; van Ree R; Tas SW; Geijtenbeek TBH; Jiskoot W; Slütter B; de Jong EC
J Pharm Sci; 2022 Apr; 111(4):1081-1091. PubMed ID: 35114209
[TBL] [Abstract][Full Text] [Related]
11. Dipalmitoylation of a cellular uptake-mediating apolipoprotein E-derived peptide as a promising modification for stable anchorage in liposomal drug carriers.
Sauer I; Nikolenko H; Keller S; Abu Ajaj K; Bienert M; Dathe M
Biochim Biophys Acta; 2006 Apr; 1758(4):552-61. PubMed ID: 16681993
[TBL] [Abstract][Full Text] [Related]
12. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
[TBL] [Abstract][Full Text] [Related]
13. Cell penetrating peptide amphiphile integrated liposomal systems for enhanced delivery of anticancer drugs to tumor cells.
Sardan M; Kilinc M; Genc R; Tekinay AB; Guler MO
Faraday Discuss; 2013; 166():269-83. PubMed ID: 24611282
[TBL] [Abstract][Full Text] [Related]
14. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W
J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760
[TBL] [Abstract][Full Text] [Related]
15. Cationic Nanoliposomes Are Efficiently Taken up by Alveolar Macrophages but Have Little Access to Dendritic Cells and Interstitial Macrophages in the Normal and CpG-Stimulated Lungs.
Vanbever R; Loira-Pastoriza C; Dauguet N; Hérin C; Ibouraadaten S; Vanvarenberg K; Ucakar B; Tyteca D; Huaux F
Mol Pharm; 2019 May; 16(5):2048-2059. PubMed ID: 30965005
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I.
Arshad N; Cresswell P
J Biol Chem; 2018 Jun; 293(25):9555-9569. PubMed ID: 29769311
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of GHK peptide-heparin interactions in multifunctional liposomal covering.
Nikolaeva V; Kamalov M; Abdullin TI; Salakhieva D; Chasov V; Rogov A; Zoughaib M
J Liposome Res; 2024 Mar; 34(1):18-30. PubMed ID: 37144381
[TBL] [Abstract][Full Text] [Related]
18. The design of peptide-amphiphiles as functional ligands for liposomal anticancer drug and gene delivery.
Kuang H; Ku SH; Kokkoli E
Adv Drug Deliv Rev; 2017 Feb; 110-111():80-101. PubMed ID: 27539561
[TBL] [Abstract][Full Text] [Related]
19. Investigating the functionalization of liposomes with NFL-TBS. 40-63 peptide as a promising drug delivery system.
Jourdain MA; Dupont A; Lautram N; Eyer J
Int J Pharm; 2024 Mar; 652():123805. PubMed ID: 38237710
[TBL] [Abstract][Full Text] [Related]
20. From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker.
Gray BP; Li S; Brown KC
Bioconjug Chem; 2013 Jan; 24(1):85-96. PubMed ID: 23186007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
